Hi, does anyone have and is willing to share Cowen's Therapeutic Outlooks for late 2022/early 2023. I understand these are fairly large documents, so I appreciate PMing.
Many Thanks! I'm hoping it will aid my understanding of the healthcare/ life sciences/ biotech investment banking landscape.
| +195 | Evercore > Goldman and I don’t think it’s particularly close anymore | 69 | 11m |
| +158 | Article: Why UBS's Asian M&A bankers are thriving and UBS's American M&A bankers are not | 18 | 2h |
| +109 | Think Twice before Recruiting for HOUSTON IB!! | 59 | 1h |
| +86 | UBS Offer Day | 34 | 1h |
| +74 | I hate Wells Fargo | 20 | 4h |
| +53 | No return offer - feeling like a failure is an understatement | 24 | 4h |
| +49 | How cooked am I as an incoming WF IB SA 2027? | 17 | 1d |
| +47 | WF Return offers | 31 | 28m |
| +41 | 2026 Investment Banking Return Offer Climate | 25 | 2d |
| +39 | Should I go back into a junior IBD role for comp? | 17 | 32m |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Similique natus sapiente et nemo quasi aut. Velit amet minus quas consequuntur sit necessitatibus voluptatem. Dolorem aut ut sed aut consequuntur at.
Nihil dolore illo aut id dicta voluptatem. Nisi ipsum dolorem expedita sint labore. Sed vel accusantium est blanditiis doloremque. Qui eum ea quis itaque commodi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...